W ANTHONY VERNON Insider Trading $NVCR NovoCure Ltd
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for W ANTHONY VERNON.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of W ANTHONY VERNON. W ANTHONY VERNON is Director in MCCORMICK & CO INC ($MKC) and Director in MEDIVATION, INC. ($MDVN) and in Intersect ENT, Inc. ($XENT) and Director in Intersect ENT, Inc. ($XENT) and Director in Kraft Foods Group, Inc. ($KRFT) and Director in WHITEWAVE FOODS Co ($WWAV) and Director in Axovant Sciences Ltd. ($AXON) and Director in Novocure Ltd ($NVCR) and Director in Nuvation Bio Inc. ($PANA).
W ANTHONY VERNON in NovoCure Ltd
Industry: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
Position of W ANTHONY VERNON: Director
Holdings: 161,130 shares
Current Value: $1,095,684
Latest Transaction: Jun 12 2020
$NVCR Market Capitalization: $581.43M
$NVCR Previous Close: $6.80
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of W ANTHONY VERNON in NovoCure Ltd
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, XENT, KRFT, MKC, MDVN, NVCR, NUVB, AXON, WWAV
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 12 2020 | NVCR | NovoCure Ltd | VERNON W ANTHONY | Director | Option Exercise | A | 67.89 | 5,101 | 346,307 | 5,101 | |
| Jun 12 2020 | NVCR | NovoCure Ltd | VERNON W ANTHONY | Director | Grant | A | 0.00 | 2,541 | 0 | 161,130 | 158.6 K to 161.1 K (+1.60 %) |
| Sep 03 2019 | NVCR | NovoCure Ltd | VERNON W ANTHONY | Director | Sell | S | 91.03 | 100,000 | 9,103,100 | 158,589 | 258.6 K to 158.6 K (-38.67 %) |
| May 24 2019 | NVCR | NovoCure Ltd | VERNON W ANTHONY | Director | Option Exercise | A | 51.36 | 6,340 | 325,622 | 6,340 | |
| May 24 2019 | NVCR | NovoCure Ltd | VERNON W ANTHONY | Director | Grant | A | 0.00 | 3,359 | 0 | 258,589 | 255.2 K to 258.6 K (+1.32 %) |
| May 22 2019 | NVCR | NovoCure Ltd | VERNON W ANTHONY | Director | Option Exercise | M | 0.00 | 6,145 | 0 | 0 | |
| May 22 2019 | NVCR | NovoCure Ltd | VERNON W ANTHONY | Director | Buy | M | 48.87 | 6,145 | 300,306 | 255,230 | 249.1 K to 255.2 K (+2.47 %) |
| Jun 04 2018 | NVCR | NovoCure Ltd | VERNON W ANTHONY | Director | Option Exercise | A | 0.00 | 6,145 | 0 | 6,145 | |
| Jun 04 2018 | NVCR | NovoCure Ltd | VERNON W ANTHONY | Director | Option Exercise | A | 31.45 | 12,345 | 388,250 | 12,345 | |
| May 12 2017 | NVCR | Novocure Ltd | VERNON W ANTHONY | Director | Option Exercise | A | 12.30 | 23,600 | 290,280 | 23,600 | |
| May 17 2016 | NVCR | Novocure Ltd | VERNON W ANTHONY | Director | Option Exercise | M | 0.17 | 249,085 | 42,344 | 0 | |
| May 17 2016 | NVCR | Novocure Ltd | VERNON W ANTHONY | Director | Buy | M | 0.17 | 249,085 | 42,344 | 249,085 | 0 to 249.1 K |
| May 06 2016 | NVCR | Novocure Ltd | VERNON W ANTHONY | Director | Option Exercise | A | 11.39 | 21,500 | 244,885 | 21,500 |
Page: 1